Drugs / mRNA-2416
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03323398 | Aug 2017 → Aug 2021 | ovarian cancer | ModernaTX, Inc. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA-2416 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03323398 ↗ |
| Modality | Messenger RNA (mRNA) | “mRNA Encoding Human OX40L” NCT03323398 ↗ |